Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

NCT04225676 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to slow enrollment

Conditions

Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: Tisagenlecleucel

Sponsor

Novartis Pharmaceuticals